GlaxoSmithKline Pharmaceuticals Limited will halt share trading following Q2 2026 results Back
<p>GlaxoSmithKline Pharmaceuticals Limited will close its trading window for share purchases and sales from October 1, 2026, until 48 hours after the announcement of its unaudited financial results for the second quarter and half year ended September 30, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations 2015.</p>